10.50 - 11.12
3.81 - 12.83
1.80M / 1.61M (Avg.)
158.14 | 0.07
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
79.20%
Gross profit growth above 1.5x OR's 15.76%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
57.98%
EBIT growth 50-75% of OR's 80.76%. Martin Whitman would suspect suboptimal resource allocation.
57.14%
Operating income growth at 50-75% of OR's 80.76%. Martin Whitman would doubt the firm’s ability to compete efficiently.
55.69%
Net income growth at 50-75% of OR's 76.69%. Martin Whitman would question fundamental disadvantages in expenses or demand.
56.03%
EPS growth at 50-75% of OR's 76.71%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
55.94%
Diluted EPS growth at 50-75% of OR's 76.71%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.39%
Share change of 0.39% while OR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
0.39%
Diluted share change of 0.39% while OR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
53.18%
OCF growth above 1.5x OR's 33.36%. David Dodd would confirm a clear edge in underlying cash generation.
-177.05%
Negative FCF growth while OR is at 89.12%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-109.63%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-5849.80%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-746.64%
Negative 3Y OCF/share CAGR while OR stands at 83.47%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-1416.20%
Negative 10Y net income/share CAGR while OR is at 8.50%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-600.04%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-447.13%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
40.96%
Equity/share CAGR of 40.96% while OR is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
809.76%
Equity/share CAGR of 809.76% while OR is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
1934.19%
Positive short-term equity growth while OR is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
No Data
No Data available this quarter, please select a different quarter.
-2.94%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-4.62%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
50.78%
We have some new debt while OR reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-25.40%
We cut SG&A while OR invests at 20.07%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.